Methods 56 patients with SCLC were randomly divided into treatment group and control group receiving ce (Carboplatin, Etoposide VP-16) regimen plus Lifein or ce regimen alone respectively.
方法将56例小细胞肺癌患者以随机方式分为治疗组ce(卡铂、VP - 16)方案化疗并用力尔凡和对照组单用CE方案化疗。
Methods 56 patients with SCLC were randomly divided into treatment group and control group receiving ce (Carboplatin, Etoposide VP-16) regimen plus Lifein or ce regimen alone respectively.
方法将56例小细胞肺癌患者以随机方式分为治疗组ce(卡铂、VP - 16)方案化疗并用力尔凡和对照组单用CE方案化疗。
应用推荐